Will Demand for Rapid COVID-19 Tests Help Abbott Laboratories Beat the Market in 2022?

Published on 16 Jan 2022 on Motley Fool

In particular, Abbott Laboratories (NYSE: ABT) makes BinaxNOW kits, which are the most popular rapid...

Read the rest of the article

Start tracking your investments with Statfolio

Key Insights Abbott Laboratories to hold its Annual General Meeting on 26th of AprilTotal pay for...

Simply Wall St. via Yahoo Finance 20 Apr 2024

Abbott Laboratories (NYSE:ABT) Q1 2024 Earnings Call Transcript April 17, 2024 Abbott Laboratorie...

Insider Monkey via Yahoo Finance 18 Apr 2024

In this article, we will take a look into Abbott Laboratories's (NYSE:ABT) DCF analysis, a reliab...

GuruFocus.com via Yahoo Finance 17 Apr 2024

Abbott Laboratories' first-quarter earnings on Wednesday exceeded analyst expectations, but its ...

Investopedia 17 Apr 2024

Abbott Laboratories (ABT) stock fell even as its Q1 2024 results exceeded estimates despite a con...

Seeking Alpha 17 Apr 2024

Shares surged 14% after the airline posted a narrower-than-expected loss in the first quarter....

CNBC 17 Apr 2024

Two implanted heart devices used by patients in end-stage heart failure are now under a strict U....

United Press International via Yahoo News 17 Apr 2024

Image source: The Motley Fool. Abbott Laboratories (NYSE: ABT)Q1 2024 Earnings CallApr 17, 2024, ...

Motley Fool via Yahoo Finance 17 Apr 2024

Abbott Laboratories came in Wednesday with a "solid" first-quarter report, but Abbott stock slipp...

Investor's Business Daily 17 Apr 2024

(Reuters) -Abbott Laboratories beat Wall Street estimates for quarterly profit on Wednesday on...

Reuters via Yahoo News 17 Apr 2024